池晓玲教授对肝硬化的证治经验
|
摘要
肝硬化主要是因为慢性肝脏疾病发生反复的中末期阶段,会产生很高的死亡率、预后较差以及并发其他病情复杂的经。池晓玲教授证治肝硬变,提倡个体化治疗,其中"辨证、辨病、辨质"相结合是治疗过程中重要方面。主张中西互补,各有侧重,提高治疗肝硬变的疗效。肝硬变的产生主要是因为慢性肝脏疾病反复发生,主要存在于疾病发展的中末期,具有较高死亡率,不良预后以及并发复杂的其他疾病。现代医学对其治疗并未收到较好的效果,并花销较大,同时肯能引起其他并发症的发生~([1-2]),池晓玲教授现任广东省中医院主任医师和博士研究生导师,现已在临床上工作时间达到20多年,在治疗肝硬化疾病方面有很多经验,故对池晓玲教授在证治肝硬化方面的经验进行综述。
Liver cirrhosis is mainly due to the recurrent middle and late stage of chronic liver disease, which produces high mortality, poor prognosis and complicated complications. Professor CHI Xiaoling is an expert in treating cirrhosis and promoting individualized treatment. The combination of syndrome differentiation, disease differentiation and differentiation is important in the treatment process. It advocates that both Chinese and western should complement each other and focus on improving the curative effect of cirrhosis. Liver cirrhosis is mainly caused by chronic liver disease, which mainly exists in the middle and late stages of disease development, with high mortality, poor prognosis and complicated other diseases. Modern medicine has no good effect on its treatment, and it has a large cost and can cause of other complications~([1-2]). Professor CHI Xiaoling is now the chief physician of Guangdong Province Traditional Chinese Medical Hospital and the supervisor of the doctoral graduate student. She has been working for more than 20 years in clinic, and has a lot of experience in the treatment of liver cirrhosis. This study is a review of Professor CHI Xiaoling's experience on the treatment of liver cirrhosis.
Liver cirrhosis is mainly due to the recurrent middle and late stage of chronic liver disease, which produces high mortality, poor prognosis and complicated complications. Professor CHI Xiaoling is an expert in treating cirrhosis and promoting individualized treatment. The combination of syndrome differentiation, disease differentiation and differentiation is important in the treatment process. It advocates that both Chinese and western should complement each other and focus on improving the curative effect of cirrhosis. Liver cirrhosis is mainly caused by chronic liver disease, which mainly exists in the middle and late stages of disease development, with high mortality, poor prognosis and complicated other diseases. Modern medicine has no good effect on its treatment, and it has a large cost and can cause of other complications~([1-2]). Professor CHI Xiaoling is now the chief physician of Guangdong Province Traditional Chinese Medical Hospital and the supervisor of the doctoral graduate student. She has been working for more than 20 years in clinic, and has a lot of experience in the treatment of liver cirrhosis. This study is a review of Professor CHI Xiaoling's experience on the treatment of liver cirrhosis.
引文
[1] 张玉波.慢性泄泻治疗偶得[J].河南中医, 2008, 28(8):42-43.
[2] 蒋俊民.池晓玲主任医师辨治肝硬变腹水经验[J].河南中医,2009,29(2):126-158.
[3] 顾伟民.顾瑞麟诊治肝硬化腹水的经验[J].中医药临床杂志,2004,16(2):163-164.
[4] 朱海涛,孙诚谊.肝硬化对乙肝相关性肝癌根治术预后的影响[J]. 中国现代医学杂志,2018(2):57-60.
[5] 刘红虹.中西医诊治肝硬化腹水进展[J].辽宁中医杂志,2018,21(3):485-488.
[6] 蒋俊民.池晓玲教授治疗肝病经验介绍[J].辽宁中医杂志,2008,40(5):15-17.
[7] 王栋平,李娟梅,刘明坤,等. 肝硬化腹水的中医治疗现状[J].辽宁中医杂志,2018,38(2):240-242.
[8] 中华中医药学会脾胃病分会. 肝硬化腹水中医诊疗专家共识意见[J]. 临床肝胆病杂志,2017,33(9):1621-1626.
[9] 柯芳,张文军,柯芳.乙型肝炎肝硬化患者肝组织病理结果分析[J].实用诊断与治疗杂志,2008,22(4):290-291.
[10] 秦金环.乙型肝炎肝硬化反复发作的影响因素分析[J].中国实用医药,2012,7(2):83-84.
[11] 蔡高术,萧焕明,谢玉宝,等.论中医辨治肝硬化腹水的基本思路[J].中医临床研究,2016,8(14):37-38.
[12] 萧焕明,池晓玲,蒋俊民,等. 苍牛防己汤加减治疗肝硬化腹水60例疗效观察[J]. 新中医,2007,39(12):82-83.
[13] 古群山.健脾化瘀消水汤治疗肝硬化腹水120例临床观察[J].河南中医, 2004, 24(9):22-23.
[14] 池晓玲. 解毒化痞软膏外敷治疗肝硬化102例[J]. 中国中医药信息杂志,2001,8(11):68.
[15] 陈培琼,金红艳,田广俊,等. 不同中医证型肝硬化患者Hp感染与血氨水平的相关性研究[J]. 广州中医药大学学报 ,2008,25(2):157-160.
[16] 萧焕明,池晓玲,陈培琼,等. 中医药对35例肝硬化脾功能亢进症患者部分脾栓塞术后影响的临床观察[J].辽宁中医杂志,2008,40(4):45-46.
[17] 蔡高术, 萧焕明, 谢玉宝, 等. 论中医辨治肝硬化腹水的基本思路[J]. 中医临床研究,2016,8(14):37-38.
[18] 池晓玲,施梅姐,萧焕明,等. 世界中联第四届肝病国际学术大会暨海峡两岸中医肝病研讨会[C].2011:83-86.
[19] 池晓玲, 蒋俊民, 萧焕明,等. 中西医结合治疗肝硬化临床路径临床应用探讨[C]. 第三届世界中医药学会联合会肝病专业委员会学术会议,2010:119-123.
[20] 池晓玲, 施梅姐, 萧焕明. 373例乙肝肝硬化失代偿期患者证候与客观指标的相关性研究[C]. 世界中联第四届肝病国际学术大会暨海峡两岸中医肝病研讨会,2011:45-48.
[21] 池晓玲, 蒋俊民, 萧焕明,等. 中西医结合治疗肝硬化临床路径应用探讨[J].辽宁中医杂志,2010,37(5):881-883.
[2] 蒋俊民.池晓玲主任医师辨治肝硬变腹水经验[J].河南中医,2009,29(2):126-158.
[3] 顾伟民.顾瑞麟诊治肝硬化腹水的经验[J].中医药临床杂志,2004,16(2):163-164.
[4] 朱海涛,孙诚谊.肝硬化对乙肝相关性肝癌根治术预后的影响[J]. 中国现代医学杂志,2018(2):57-60.
[5] 刘红虹.中西医诊治肝硬化腹水进展[J].辽宁中医杂志,2018,21(3):485-488.
[6] 蒋俊民.池晓玲教授治疗肝病经验介绍[J].辽宁中医杂志,2008,40(5):15-17.
[7] 王栋平,李娟梅,刘明坤,等. 肝硬化腹水的中医治疗现状[J].辽宁中医杂志,2018,38(2):240-242.
[8] 中华中医药学会脾胃病分会. 肝硬化腹水中医诊疗专家共识意见[J]. 临床肝胆病杂志,2017,33(9):1621-1626.
[9] 柯芳,张文军,柯芳.乙型肝炎肝硬化患者肝组织病理结果分析[J].实用诊断与治疗杂志,2008,22(4):290-291.
[10] 秦金环.乙型肝炎肝硬化反复发作的影响因素分析[J].中国实用医药,2012,7(2):83-84.
[11] 蔡高术,萧焕明,谢玉宝,等.论中医辨治肝硬化腹水的基本思路[J].中医临床研究,2016,8(14):37-38.
[12] 萧焕明,池晓玲,蒋俊民,等. 苍牛防己汤加减治疗肝硬化腹水60例疗效观察[J]. 新中医,2007,39(12):82-83.
[13] 古群山.健脾化瘀消水汤治疗肝硬化腹水120例临床观察[J].河南中医, 2004, 24(9):22-23.
[14] 池晓玲. 解毒化痞软膏外敷治疗肝硬化102例[J]. 中国中医药信息杂志,2001,8(11):68.
[15] 陈培琼,金红艳,田广俊,等. 不同中医证型肝硬化患者Hp感染与血氨水平的相关性研究[J]. 广州中医药大学学报 ,2008,25(2):157-160.
[16] 萧焕明,池晓玲,陈培琼,等. 中医药对35例肝硬化脾功能亢进症患者部分脾栓塞术后影响的临床观察[J].辽宁中医杂志,2008,40(4):45-46.
[17] 蔡高术, 萧焕明, 谢玉宝, 等. 论中医辨治肝硬化腹水的基本思路[J]. 中医临床研究,2016,8(14):37-38.
[18] 池晓玲,施梅姐,萧焕明,等. 世界中联第四届肝病国际学术大会暨海峡两岸中医肝病研讨会[C].2011:83-86.
[19] 池晓玲, 蒋俊民, 萧焕明,等. 中西医结合治疗肝硬化临床路径临床应用探讨[C]. 第三届世界中医药学会联合会肝病专业委员会学术会议,2010:119-123.
[20] 池晓玲, 施梅姐, 萧焕明. 373例乙肝肝硬化失代偿期患者证候与客观指标的相关性研究[C]. 世界中联第四届肝病国际学术大会暨海峡两岸中医肝病研讨会,2011:45-48.
[21] 池晓玲, 蒋俊民, 萧焕明,等. 中西医结合治疗肝硬化临床路径应用探讨[J].辽宁中医杂志,2010,37(5):881-883.